M16.1 T81.8
Conditions
Interventions
Group 1: The observational study seeks to evaluate retrospective data of coxarthrosis patients with hip TEP implants using AMIS DAA. The patient group is made up of routine treatment cases at our clin
Sponsors
ACURA Kliniken Albstadt GmbH
Eligibility
Sex/Gender
All
Age
30 Years to 80 Years
Inclusion criteria
Inclusion criteria: - Coxarthrosis - Male and female patients between 30 an 80 years of Age Patients who had undergone a programmed total hip replacemenet surgery in AMIS DAA and had a 4 week postoperative medical Observation -Compliance with the ordered postoperative medical Treatment - Agreement in written form of the participating Person - full contractual capability
Exclusion criteria
Exclusion criteria: - Hip replacement after hip fracture - Intolerance to plaster - Addiction oder other diseases that don´t allow the patient to follow the postoperative regime - Oral anticoagulation in medical history - Corticoide treatment or other immunsupressive treatment - local skin abnormalities
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Frequency of intraoperative and perioperative trochanter avulsion fractures and trochanter infraction Frequency of wound healing disorders following the implantation of total hip endoprostheses through minimally invasive access The endpoint is the last clinical and if necessary the last radiological examination at the end of the rehabilitation programme about 4 weeks after surgery. | — |
Secondary
| Measure | Time frame |
|---|---|
| Incidence of revision due to seromas/hematomas Incidence of revision due to fractures Incidence of revision due to wound healing disorders Incidence of revision in total The endpoint is the last clinical and if necessary the last radiological examination at the end of the rehabilitation programme about 4 weeks after surgery. | — |
Countries
Germany
Contacts
Public ContactEmese Scholl
ACURA Kliniken Albstadt GmbH
Outcome results
None listed